|Original language||English (US)|
|Number of pages||2|
|Journal||JAMA - Journal of the American Medical Association|
|State||Published - Sep 1 2020|
Bibliographical noteFunding Information:
Gilead, Intercept, Conatus, and Genfit. Dr Ikramuddin reported receiving grant support from ReShape Life Sciences and equipment from Medtronic. No other disclosures were reported.
Conflict of Interest Disclosures: Dr Lin reported receiving grants from the National Institute of Diabetes and Digestive and Kidney Diseases and personal
PubMed: MeSH publication types